Anti-tuberculosis drug concentrations in tuberculosis patients with and without diabetes mellitus

被引：0
作者：
A K Hemanth Kumar
V Chandrasekaran
T Kannan
A Lakshmi Murali
J Lavanya
V Sudha
Soumya Swaminathan
Geetha Ramachandran
机构：
[1] National Institute for Research in Tuberculosis,Department of Biochemistry and Clinical Pharmacology
[2] State TB Officer,undefined
[3] District TB Officer,undefined
来源：
European Journal of Clinical Pharmacology | 2017年 / 73卷
关键词：
Tuberculosis; Anti-tuberculosis drug concentrations; Revised National Tuberculosis Control Programme; Diabetes mellitus;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：65 / 70
页数：5
相关论文
共 50 条
  • [21] Is resistance to anti-tuberculosis drugs associated with type 2 diabetes mellitus? A register review in Beijing, China
    Mi, Fengling
    Jiang, Guanglu
    Du, Jian
    Li, Liang
    Yue, Wentao
    Harries, Anthony D.
    Hinderaker, Sven Gudmund
    Lin, Yan
    GLOBAL HEALTH ACTION, 2014, 7 : 1 - 7
  • [22] Patients with secondary amenorrhea due to tuberculosis endometritis towards the induced anti-tuberculosis drug category 1
    Perdhana, Raditya
    Sutrisno, Sutrisno
    Sugiri, Yani Jane
    Baktiyani, Siti Candra Windu
    Wiyasa, Arsana
    PAN AFRICAN MEDICAL JOURNAL, 2016, 24
  • [23] Anti-Tuberculosis Drug Induced Hepatotoxicity and Associated Factors among Tuberculosis Patients at Selected Hospitals, Ethiopia
    Molla, Yalew
    Wubetu, Muluken
    Dessie, Bekalu
    HEPATIC MEDICINE-EVIDENCE AND RESEARCH, 2021, 13 : 1 - 8
  • [24] Anti-tuberculosis drug resistance in strains of Mycobacterium tuberculosis isolated from patients in a tertiary hospital in Bahia
    Matos, Eliana Dias
    Moreira Lemos, Antonio Carlos
    Bittencourt, Carolina
    Mesquita, Cristiane Leite
    BRAZILIAN JOURNAL OF INFECTIOUS DISEASES, 2007, 11 (03) : 331 - 338
  • [25] Second-line anti-tuberculosis drug concentrations for susceptibility testing in the MODS assay
    Patrick Fitzwater, Sean
    Andrew Sechler, G.
    Jave, Oswaldo
    Coronel, Jorge
    Mendoza, Alberto
    Gilman, Robert H.
    Friedland, Jon S.
    Moore, David A. J.
    EUROPEAN RESPIRATORY JOURNAL, 2013, 41 (05) : 1163 - 1171
  • [26] Transcriptional profiles predict treatment outcome in patients with tuberculosis and diabetes at diagnosis and at two weeks after initiation of anti-tuberculosis treatment
    van Doorn, Cassandra L. R.
    Eckold, Clare
    Ronacher, Katharina
    Ruslami, Rovina
    van Veen, Suzanne
    Lee, Ji-Sook
    Kumar, Vinod
    Kerry-Barnard, Sarah
    Malherbe, Stephanus T.
    Kleynhans, Leanie
    Stanley, Kim
    Hill, Philip C.
    Joosten, Simone A.
    van Crevel, Reinout
    Wijmenga, Cisca
    Critchley, Julia A.
    Walzl, Gerhard
    Alisjahbana, Bachti
    Haks, Marielle C.
    Dockrell, Hazel M.
    Ottenhoff, Tom H. M.
    Vianello, Eleonora
    Cliff, Jacqueline M.
    EBIOMEDICINE, 2022, 82
  • [27] A review on anti-tuberculosis peptides: Impact of peptide structure on anti-tuberculosis activity
    Yathursan, Sutharsana
    Wiles, Siouxsie
    Read, Hannah
    Sarojini, Vijayalekshmi
    JOURNAL OF PEPTIDE SCIENCE, 2019, 25 (11)
  • [28] Hypercalcaemia in Greek patients with tuberculosis before the initiation of anti-tuberculosis treatment
    Roussos, A
    Lagogianni, I
    Gonis, A
    Ilias, I
    Kazi, D
    Patsopoulos, D
    Philippou, N
    RESPIRATORY MEDICINE, 2001, 95 (03) : 187 - 190
  • [29] The epidemiology of tuberculosis and resistance to anti-tuberculosis drugs
    Khaled, NA
    Enarson, D
    Billo, N
    REVUE DES MALADIES RESPIRATOIRES, 1997, 14 : S8 - S18
  • [30] Anti-tuberculosis drug resistance in two clinics in Ecuador
    Mertz, BL
    Douce, RW
    Brito, N
    INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE, 2000, 4 (02) : 115 - 117
12345